Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+3.38M
-
Total reported value, excl. options
-
$761M
-
Value change
-
+$42.2M
-
Put/Call ratio
-
0.9
-
Number of buys
-
85
-
Number of sells
-
-58
-
Price
-
$14.24
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q3 2021
168 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q3 2021.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 127M outstanding shares and own 42.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.07M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (7.46M shares), VANGUARD GROUP INC (4.19M shares), STATE STREET CORP (4.06M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.12M shares), NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC (1.64M shares), MORGAN STANLEY (1.43M shares), MACQUARIE GROUP LTD (1.24M shares), Assenagon Asset Management S.A. (1.13M shares), and Nuveen Asset Management, LLC (1.02M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.